Exercise Performance and Effects of Exercise Training in Diabetes

  • Irene Schauer
  • Tim Bauer
  • Peter Watson
  • Judith Regensteiner
  • Jane E.B. Reusch
Part of the Contemporary Diabetes book series (CDI)


There is a well established relationship between physical activity, metabolism, diabetes, and cardiovascular risk. In fact, numerous prospective epidemiological studies demonstrate an inverse correlation between physical activity and mortality, both cardiovascular and all cause mortality. This association is plausible when considered in the context of the impact of physical activity upon metabolic parameters that modulate cardiovascular risk such as blood pressure, dyslipidemia, inflammatory markers, and carbohydrate tolerance. Exercise is also pivotal for weight maintenance and prevention of obesity, a leading cause of new onset diabetes, which in turn contributes significantly to cardiovascular disease burden and mortality, as well as to noncardiac and all cause mortality. Prospective studies demonstrate the ability of diet and exercise to prevent progression from impaired glucose tolerance to diabetes. Despite the salutary effects of exercise on diabetes and cardiovascular risk, recent literature indicates that people with diabetes do not exercise as much as those without. This failure to exercise is likely behavioral and functional. Our recent work demonstrates that there are defects in both maximal and submaximal exercise function in persons with type 2 diabetes mellitus. In this chapter, we will review the cardiovascular and metabolic impacts of exercise, the relationship of exercise to diabetes prevention, and work from our lab examining the impact of diabetes on exercise capacity with some insights into the general mechanisms likely to be involved. The later chapters in this section will outline the impact of exercise on body composition and on cardiac, skeletal muscle, and endothelial function in additional detail .

Diabetes Exercise Cardiovascular Endothelial dysfunction Insulin sensitivity Myocardialdysfunction. 


  1. 1.
    1. Blair SN, Wei M. Sedentary habits, health, and function in older women and men. Am J Health Promot. Sep–Oct 2000;15(1):1–8.PubMedGoogle Scholar
  2. 2.
    2. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with T2DM. Ann Intern Med. Apr 18 2000;132(8):605–611.PubMedGoogle Scholar
  3. 3.
    3. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. Oct 27 1999;282(16):1547–1553.PubMedGoogle Scholar
  4. 4.
    4. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care. Feb 2005;28(2):391–397.PubMedGoogle Scholar
  5. 5.
    5. Sundquist K, Qvist J, Sundquist J, Johansson SE. Frequent and occasional physical activity in the elderly: a 12-year follow-up study of mortality. Am J Prev Med. Jul 2004;27(1):22–27.PubMedGoogle Scholar
  6. 6.
    6. Church TS, Cheng YJ, Earnest CP, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care. Jan 2004;27(1):83–88.PubMedGoogle Scholar
  7. 7.
    7. Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc. May 2001;33(5):754–761.PubMedGoogle Scholar
  8. 8.
    8. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med. Jun 23 2003;163(12):1440–1447.PubMedGoogle Scholar
  9. 9.
    9. Myers J, Kaykha A, George S, et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med. Dec 15 2004;117(12):912–918.PubMedGoogle Scholar
  10. 10.
    10. Lees SJ, Booth FW. Sedentary death syndrome. Can J Appl Physiol. Aug 2004;29(4):447–460; discussion 444–446.PubMedGoogle Scholar
  11. 11.
    11. Allen F, Stillman E, Fitz, R. Total dietary regulation in the treatment of diabetes. Exercise, Vol 11. NY: Rockefeller Institute of Medical Research; 1919:486–499.Google Scholar
  12. 12.
    12. Rogers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care. Sep 1988;11(8):613–618.PubMedGoogle Scholar
  13. 13.
    13. Wei M, Schwertner HA, Blair SN. The association between physical activity, physical fitness, and T2DM mellitus. Compr Ther. Fall 2000;26(3):176–182.PubMedGoogle Scholar
  14. 14.
    14. Ruderman N, Apelian AZ, Schneider SH. Exercise in therapy and prevention of type II diabetes. Implications for blacks. Diabetes Care. Nov 1990;13(11):1163–1168.PubMedGoogle Scholar
  15. 15.
    15. Schneider SH, Khachadurian AK, Amorosa LF, Clemow L, Ruderman NB. Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care. Nov 1992;15(11):1800–1810.PubMedGoogle Scholar
  16. 16.
    16. Schneider SH, Elouzi EB. The role of exercise in type II diabetes mellitus. Prev Cardiol. Spring 2000;3(2):77–82.PubMedGoogle Scholar
  17. 17.
    17. Eves ND, Plotnikoff RC. Resistance training and T2DM: considerations for implementation at the population level. Diabetes Care. Aug 2006;29(8):1933–1941.PubMedGoogle Scholar
  18. 18.
    18. Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. Feb 2007;30(2):203–209.PubMedGoogle Scholar
  19. 19.
    19. Krug LM, Haire-Joshu D, Heady SA. Exercise habits and exercise relapse in persons with non-insulin-dependent diabetes mellitus. Diabetes Educ. May–Jun 1991;17(3):185–188.PubMedGoogle Scholar
  20. 20.
    20. Baldi JC, Aoina JL, Oxenham HC, Bagg W, Doughty RN. Reduced exercise arteriovenous O2 difference in T2DM. J Appl Physiol. Mar 2003;94(3):1033–1038.PubMedGoogle Scholar
  21. 21.
    21. Scheuermann-Freestone M, Madsen PL, Manners D, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with T2DM. Circulation. Jun 24 2003;107(24):3040–3046.PubMedGoogle Scholar
  22. 22.
    22. Regensteiner JG, Bauer TA, Reusch JE, et al. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol. Jul 1998;85(1):310–317.PubMedGoogle Scholar
  23. 23.
    23. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc. Jun 1995;27(6):875–881.PubMedGoogle Scholar
  24. 24.
    24. Blair SN, Kohl HW, III, Paffenbarger RS, Jr., Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. Nov 3 1989;262(17):2395–2401.PubMedGoogle Scholar
  25. 25.
    25. Blair SN, Kohl HW, III, Barlow CE, Gibbons LW. Physical fitness and all-cause mortality in hypertensive men. Ann Med. Aug 1991;23(3):307–312.PubMedGoogle Scholar
  26. 26.
    26. Blair SN, Kampert JB, Kohl HW, III, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. Jul 17 1996;276(3):205–210.PubMedGoogle Scholar
  27. 27.
    27. Ring-Dimitriou S, von Duvillard SP, Paulweber B, et al. Nine months aerobic fitness induced changes on blood lipids and lipoproteins in untrained subjects versus controls. Eur J Appl Physiol. Feb 2007;99(3):291–299.PubMedGoogle Scholar
  28. 28.
    28. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. Nov 7 2002;347(19):1483–1492.PubMedGoogle Scholar
  29. 29.
    29. Thomas DE, Elliott EJ, Naughton GA. Exercise for T2DM mellitus. Cochrane Database Syst Rev. 2006;3:CD002968.PubMedGoogle Scholar
  30. 30.
    30. Krook A, Holm I, Pettersson S, Wallberg-Henriksson H. Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Physiol Funct Imaging. Jan 2003;23(1):21–30.PubMedGoogle Scholar
  31. 31.
    31. Hautala AJ, Leon A, Skinner JS, Rao DC, Bouchard C, Rankinen T. Peroxisome proliferator-activated receptor delta polymorphisms are associated with physical performance and plasma lipids: the HERITAGE family study. Am J Physiol Heart Circ Physiol. Jan 26 2007;292: H2498–H2505.PubMedGoogle Scholar
  32. 32.
    32. Bourey RE, Santoro SA. Interactions of exercise, coagulation, platelets, and fibrinolysis – a brief review. Med Sci Sports Exerc. Oct 1988;20(5):439–446.PubMedGoogle Scholar
  33. 33.
    33. Ribeiro J, Almeida-Dias A, Oliveira AR, Mota J, Appell HJ, Duarte JA. Exhaustive exercise with high eccentric components induces prothrombotic and hypofibrinolytic responses in boys. Int J Sports Med. Mar 2007;28(3):193–196.PubMedGoogle Scholar
  34. 34.
    34. Paton CM, Brandauer J, Weiss EP, et al. Hemostatic response to postprandial lipemia before and after exercise training. J Appl Physiol. Jul 2006;101(1):316–321.PubMedGoogle Scholar
  35. 35.
    35. Barazzoni R, Kiwanuka E, Zanetti M, Cristini M, Vettore M, Tessari P. Insulin acutely increases fibrinogen production in individuals with T2DM but not in individuals without diabetes. Diabetes. Jul 2003;52(7):1851–1856.PubMedGoogle Scholar
  36. 36.
    36. Schneider SH, Kim HC, Khachadurian AK, Ruderman NB. Impaired fibrinolytic response to exercise in type II diabetes: effects of exercise and physical training. Metabolism. Oct 1988;37(10):924–929.PubMedGoogle Scholar
  37. 37.
    37. Hornsby WG, Boggess KA, Lyons TJ, Barnwell WH, Lazarchick J, Colwell JA. Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care. Feb 1990;13(2):87–92.PubMedGoogle Scholar
  38. 38.
    38. Hamalainen H, Ronnemaa T, Virtanen A, et al. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study. Diabetologia. Nov 2005;48(11):2248–2253.PubMedGoogle Scholar
  39. 39.
    39. Kulaputana O, Macko RF, Ghiu I, Phares DA, Goldberg AP, Hagberg JM. Human gender differences in fibrinolytic responses to exercise training and their determinants. Exp Physiol. Nov 2005;90(6):881–887.PubMedGoogle Scholar
  40. 40.
    40. Jennings G, Nelson L, Nestel P, et al. The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation. Jan 1986;73(1):30–40.PubMedGoogle Scholar
  41. 41.
    41. Fagard RH, Cornelissen VA. Effect of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil. Feb 2007;14(1):12–17.PubMedGoogle Scholar
  42. 42.
    42. Lazarevic G, Antic S, Cvetkovic T, Vlahovic P, Tasic I, Stefanovic V. A physical activity programme and its effects on insulin resistance and oxidative defense in obese male patients with T2DM mellitus. Diabetes Metab. Dec 2006;32(6):583–590.PubMedGoogle Scholar
  43. 43.
    43. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. Feb 1991;83(2):391–401.PubMedGoogle Scholar
  44. 44.
    44. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. Mar 7 2000;101(9):948–954.PubMedGoogle Scholar
  45. 45.
    45. Chan NN, Colhoun HM, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol. Dec 2001;38(7):1814–1820.PubMedGoogle Scholar
  46. 46.
    46. Thanyasiri P, Celermajer DS, Adams MR. Endothelial dysfunction occurs in peripheral circulation patients with acute and stable coronary artery disease. Am J Physiol Heart Circ Physiol. Aug 2005;289(2):H513–H517.PubMedGoogle Scholar
  47. 47.
    47. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. Jul 15 2000;86(2):207–210.PubMedGoogle Scholar
  48. 48.
    48. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the “vulnerable” patient. Circulation. Oct 5 2004;110(14):1926–1932.PubMedGoogle Scholar
  49. 49.
    49. Linke A, Schoene N, Gielen S, et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol. Feb 2001;37(2):392–397.PubMedGoogle Scholar
  50. 50.
    50. Westhoff TH, Franke N, Schmidt S, et al. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives. J Hum Hypertens. Mar 1 2007;21(6):486–493.PubMedGoogle Scholar
  51. 51.
    51. Kelly AS, Wetzsteon RJ, Kaiser DR, Steinberger J, Bank AJ, Dengel DR. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr. Dec 2004;145(6):731–736.PubMedGoogle Scholar
  52. 52.
    52. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol. Nov 7 2006;48(9):1865–1870.PubMedGoogle Scholar
  53. 53.
    53. De Filippis E, Cusi K, Ocampo G, et al. Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and T2DM mellitus. J Clin Endocrinol Metab. Dec 2006;91(12):4903–4910.PubMedGoogle Scholar
  54. 54.
    54. Maiorana A, O'Driscoll G, Cheetham C, et al. The effect of combined aerobic and resistance exercise training on vascular function in T2DM. J Am Coll Cardiol. Sep 2001;38(3):860–866.PubMedGoogle Scholar
  55. 55.
    55. Zoppini G, Targher G, Zamboni C, et al. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with T2DM. Nutr Metab Cardiovasc Dis. Dec 2006;16(8):543–549.PubMedGoogle Scholar
  56. 56.
    56. Middlebrooke AR, Elston LM, Macleod KM, et al. Six months of aerobic exercise does not improve microvascular function in T2DM mellitus. Diabetologia. Oct 2006;49(10):2263–2271.PubMedGoogle Scholar
  57. 57.
    57. Ostergard T, Nyholm B, Hansen TK, et al. Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. Metabolism. Nov 2006;55(11):1508–1515.PubMedGoogle Scholar
  58. 58.
    58. Maiorana A, O'Driscoll G, Dembo L, Goodman C, Taylor R, Green D. Exercise training, vascular function, and functional capacity in middle-aged subjects. Med Sci Sports Exerc. Dec 2001;33(12):2022–2028.PubMedGoogle Scholar
  59. 59.
    59. Gleeson M. Immune function in sport and exercise. J Appl Physiol. Feb 15 2007;103:693–699.PubMedGoogle Scholar
  60. 60.
    60. Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merriam PA, Hebert JR. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc. Aug 2002;34(8):1242–1248.PubMedGoogle Scholar
  61. 61.
    61. Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness. Sep 1990;30(3):316–328.PubMedGoogle Scholar
  62. 62.
    62. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. Feb 6 2003;91(3A):3A–6A.PubMedGoogle Scholar
  63. 63.
    63. Festa A, D'Agostino R, Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Circulation. May 20 2003;107(19):2422–2427.PubMedGoogle Scholar
  64. 64.
    64. Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident T2DM. Circulation. Apr 11 2006;113(14):1753–1759.PubMedGoogle Scholar
  65. 65.
    65. Olson TP, Dengel DR, Leon AS, Schmitz KH. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes. Feb 13 2007;31(6):996–1003.Google Scholar
  66. 66.
    66. Leick L, Lindegaard B, Stensvold D, Plomgaard P, Saltin B, Pilegaard H. Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise. Obesity. Feb 2007;15(2):356–363.PubMedGoogle Scholar
  67. 67.
    67. Mattusch F, Dufaux B, Heine O, Mertens I, Rost R. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med. Jan 2000;21(1):21–24.PubMedGoogle Scholar
  68. 68.
    68. Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. Nov 2006;57 Suppl 10:43–51.PubMedGoogle Scholar
  69. 69.
    69. Marcell TJ, McAuley KA, Traustadottir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism. Apr 2005;54(4):533–541.PubMedGoogle Scholar
  70. 70.
    70. Ruderman NB, Keller C, Richard AM, et al. Interleukin-6 regulation of AMP-activated protein kinase: potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes. Dec 2006;55 Suppl 2:S48–S54.PubMedGoogle Scholar
  71. 71.
    71. Carey AL, Febbraio MA. Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia. Jul 2004;47(7):1135–1142.PubMedGoogle Scholar
  72. 72.
    72. Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, Jansson JO. Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology. Jun 2004;145(6):2680–2686.PubMedGoogle Scholar
  73. 73.
    73. Despres JP, Pouliot MC, Moorjani S, et al. Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol. Aug 1991;261(2 Part 1):E159–E167.PubMedGoogle Scholar
  74. 74.
    74. Zachwieja JJ. Exercise as treatment for obesity. Endocrinol Metab Clin North Am. Dec 1996;25(4):965–988.PubMedGoogle Scholar
  75. 75.
    75. Rodearmel SJ, Wyatt HR, Barry MJ, et al. A family-based approach to preventing excessive weight gain. Obesity. Aug 2006;14(8):1392–1401.PubMedGoogle Scholar
  76. 76.
    76. Phelan S, Wyatt HR, Hill JO, Wing RR. Are the eating and exercise habits of successful weight losers changing? Obesity. Apr 2006;14(4):710–716.PubMedGoogle Scholar
  77. 77.
    77. Pavlou KN, Krey S, Steffee WP. Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr. May 1989;49(5 Suppl):1115–1123.PubMedGoogle Scholar
  78. 78.
    78. Devlin JT, Hirshman M, Horton ED, Horton ES. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes. Apr 1987;36(4):434–439.PubMedGoogle Scholar
  79. 79.
    79. Ruderman NB, Ganda OP, Johansen K. The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes. Diabetes. Jan 1979;28Suppl 1:89–92.PubMedGoogle Scholar
  80. 80.
    80. Galassetti P, Coker RH, Lacy DB, Cherrington AD, Wasserman DH. Prior exercise increases net hepatic glucose uptake during a glucose load. Am J Physiol. Jun 1999;276(6 Part 1):E1022–E1029.PubMedGoogle Scholar
  81. 81.
    81. O'Gorman DJ, Karlsson HK, McQuaid S, et al. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with T2DM. Diabetologia. Dec 2006;49(12):2983–2992.PubMedGoogle Scholar
  82. 82.
    82. Gill JM. Physical activity, cardiorespiratory fitness and insulin resistance: a short update. Curr Opin Lipidol. Feb 2007;18(1):47–52.PubMedGoogle Scholar
  83. 83.
    83. Coker RH, Hays NP, Williams RH, et al. Exercise-induced changes in insulin action and glycogen metabolism in elderly adults. Med Sci Sports Exerc. Mar 2006;38(3):433–438.PubMedGoogle Scholar
  84. 84.
    84. DiPietro L, Dziura J, Yeckel CW, Neufer PD. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol. Jan 2006;100(1):142–149.PubMedGoogle Scholar
  85. 85.
    85. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. Nov 2006;29(11):2518–2527.PubMedGoogle Scholar
  86. 86.
    86. Kelley DE, Goodpaster BH. Effects of exercise on glucose homeostasis in T2DM mellitus. Med Sci Sports Exerc. Jun 2001;33(6 Suppl):S495–S501; discussion S528–S599.PubMedGoogle Scholar
  87. 87.
    87. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of T2DM mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. May 3 2001;344(18):1343–1350.PubMedGoogle Scholar
  88. 88.
    88. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. Apr 1997;20(4):537–544.PubMedGoogle Scholar
  89. 89.
    89. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of T2DM with lifestyle intervention or metformin. N Engl J Med. Feb 7 2002;346(6):393–403.PubMedGoogle Scholar
  90. 90.
    90. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog Cardiovasc Dis. Mar–Apr 1984;26(5):373–412.PubMedGoogle Scholar
  91. 91.
    91. Schneider SH, Vitug A, Ruderman N. Atherosclerosis and physical activity. Diabetes Metab Rev. 1986;1(4):513–553.Google Scholar
  92. 92.
    92. Brandenburg SL, Reusch JE, Bauer TA, Jeffers BW, Hiatt WR, Regensteiner JG. Effects of exercise training on oxygen uptake kinetic responses in women with T2DM. Diabetes Care. Oct 1999;22(10):1640–1646.PubMedGoogle Scholar
  93. 93.
    93. Kemmer FW, Tacken M, Berger M. Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment. Diabetes. Oct 1987;36(10):1178–1182.PubMedGoogle Scholar
  94. 94.
    94. Kjaer M, Hollenbeck CB, Frey-Hewitt B, Galbo H, Haskell W, Reaven GM. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. J Appl Physiol. May 1990;68(5):2067–2074.PubMedGoogle Scholar
  95. 95.
    95. Schneider SH, Khachadurian AK, Amorosa LF, Gavras H, Fineberg SE, Ruderman NB. Abnormal glucoregulation during exercise in type II (non-insulin-dependent) diabetes. Metabolism. Dec 1987;36(12):1161–1166.PubMedGoogle Scholar
  96. 96.
    96. Saltin B, Lindgarde F, Houston M, Horlin R, Nygaard E, Gad P. Physical training and glucose tolerance in middle-aged men with chemical diabetes. Diabetes. Jan 1979;28Suppl 1:30–32.PubMedGoogle Scholar
  97. 97.
    97. Wasserman K, Hansen JE, Sue DY, Whipp BJ, Casaburi R. Principles of Exercise Testing and Interpretation, Second ed. London: Lea & Febiger, 1994.Google Scholar
  98. 98.
    98. Hansen JE, Sue DY, Oren A, Wasserman K. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol. Mar 1 1987;59(6):669–674.PubMedGoogle Scholar
  99. 99.
    99. Barstow TJ, Mole PA. Simulation of pulmonary O2 uptake during exercise transients in humans. J Appl Physiol. Dec 1987;63(6):2253–2261.PubMedGoogle Scholar
  100. 100.
    100. Whipp B, Mahler M. Dynamics of pulmonary gas exchange during exercise In: West J, ed. Pulmonary Gas Exchange, Vol 2. New York: Academic; 1980:33–96.Google Scholar
  101. 101.
    101. Grassi B, Poole DC, Richardson RS, Knight DR, Erickson BK, Wagner PD. Muscle O2 uptake kinetics in humans: implications for metabolic control. J Appl Physiol. Mar 1996;80(3):988–998.PubMedGoogle Scholar
  102. 102.
    102. Rossiter HB, Ward SA, Doyle VL, Howe FA, Griffiths JR, Whipp BJ. Inferences from pulmonary O2 uptake with respect to intramuscular [phosphocreatine] kinetics during moderate exercise in humans. J Physiol. Aug 1 1999;518 (Part 3):921–932.PubMedGoogle Scholar
  103. 103.
    103. Jones AM, Poole DC. Oxygen uptake dynamics: from muscle to mouth – an introduction to the symposium. Med Sci Sports Exerc. Sep 2005;37(9):1542–1550.PubMedGoogle Scholar
  104. 104.
    104. Sietsema KE. Oxygen uptake kinetics in response to exercise in patients with pulmonary vascular disease. Am Rev Respir Dis. May 1992;145(5):1052–1057.PubMedGoogle Scholar
  105. 105.
    105. Sietsema KE, Cooper DM, Perloff JK, et al. Dynamics of oxygen uptake during exercise in adults with cyanotic congenital heart disease. Circulation. Jun 1986;73(6):1137–1144.PubMedGoogle Scholar
  106. 106.
    106. Wasserman K. Overview and future directions. Circulation. Jan 1990;81(1 Suppl):II59–II64.PubMedGoogle Scholar
  107. 107.
    107. Bauer TA, Reusch JE, Levi M, Regensteiner JG. Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes. Diabetes Care. Nov 2007; 30(11): 2880–2885.PubMedGoogle Scholar
  108. 108.
    108. Modan M, Meytes D, Rozeman P, et al. Significance of high HbA1 levels in normal glucose tolerance. Diabetes Care. May 1988;11(5):422–428.PubMedGoogle Scholar
  109. 109.
    109. Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia. May 1984;26(5):355–360.PubMedGoogle Scholar
  110. 110.
    110. Regensteiner JG, Bauer TA, Reusch JE. Rosiglitazone improves exercise capacity in individuals with T2DM. Diabetes Care. Dec 2005;28(12):2877–2883.PubMedGoogle Scholar
  111. 111.
    111. Reusch JE, Regensteiner JG, Watson PA. Novel actions of thiazolidinediones on vascular function and exercise capacity. Am J Med. Dec 8 2003;115 Suppl 8A:69S–74S.PubMedGoogle Scholar
  112. 112.
    112. Seibaek M, Vestergaard H, Burchardt H, et al. Insulin resistance and maximal oxygen uptake. Clin Cardiol. Nov 2003;26(11):515–520.PubMedGoogle Scholar
  113. 113.
    113. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia. May 1995;38(5):565–572.PubMedGoogle Scholar
  114. 114.
    114. Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. Aug 1997;30(2):527–532.PubMedGoogle Scholar
  115. 115.
    115. Orio F, Jr, Giallauria F, Palomba S, et al. Cardiopulmonary impairment in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. Aug 2006;91(8):2967–2971.PubMedGoogle Scholar
  116. 116.
    116. Wong CY, O'Moore-Sullivan T, Fang ZY, Haluska B, Leano R, Marwick TH. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol. Dec 15 2005;96(12):1686–1691.PubMedGoogle Scholar
  117. 117.
    117. Endre T, Mattiasson I, Hulthen UL, Lindgarde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens. Jan 1994;12(1):81–88.PubMedGoogle Scholar
  118. 118.
    118. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. Mar 1 1996;27(3):567–574.PubMedGoogle Scholar
  119. 119.
    119. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. Aug 1992;35(8):771–776.PubMedGoogle Scholar
  120. 120.
    120. Kingwell BA, Formosa M, Muhlmann M, Bradley SJ, McConell GK. Type 2 diabetic individuals have impaired leg blood flow responses to exercise: role of endothelium-dependent vasodilation. Diabetes Care. Mar 2003;26(3):899–904.PubMedGoogle Scholar
  121. 121.
    121. Regensteiner JG, Popylisen S, Bauer TA, et al. Oral l-arginine and vitamins E and C improve endothelial function in women with T2DM. Vasc Med. 2003;8(3):169–175.Google Scholar
  122. 122.
    122. Yki-Jarvinen H. Insulin resistance and endothelial dysfunction. Best Pract Res Clin Endocrinol Metab. Sep 2003;17(3):411–430.PubMedGoogle Scholar
  123. 123.
    123. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. Jun 1 1996;97(11):2601–2610.PubMedGoogle Scholar
  124. 124.
    124. Borlaug BA, Melenovsky V, Russell SD, et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation. Nov 14 2006;114(20):2138–2147.PubMedGoogle Scholar
  125. 125.
    125. Jones AM, Wilkerson DP, Campbell IT. Nitric oxide synthase inhibition with l-NAME reduces maximal oxygen uptake but not gas exchange threshold during incremental cycle exercise in man. J Physiol. Oct 1 2004;560 (Part 1):329–338.PubMedGoogle Scholar
  126. 126.
    126. Jones AM, Wilkerson DP, Koppo K, Wilmshurst S, Campbell IT. Inhibition of nitric oxide synthase by l-NAME speeds phase II pulmonary.VO2 kinetics in the transition to moderate-intensity exercise in man. J Physiol. Oct 1 2003;552 (Part 1):265–272.PubMedGoogle Scholar
  127. 127.
    127. Recchia FA, Osorio JC, Chandler MP, et al. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol Endocrinol Metab. Jan 2002;282(1):E197–E206.PubMedGoogle Scholar
  128. 128.
    128. Xie YW, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res. Sep 1996;79(3):381–387.PubMedGoogle Scholar
  129. 129.
    129. Shen W, Hintze TH, Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation. Dec 15 1995;92(12):3505–3512.PubMedGoogle Scholar
  130. 130.
    130. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W, Hintze TH. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc. Aug 1995;27(8):1125–1134.PubMedGoogle Scholar
  131. 131.
    131. Baldi JC, Aoina JL, Whalley GA, et al. The effect of T2DM on diastolic function. Med Sci Sports Exerc. Aug 2006;38(8):1384–1388.PubMedGoogle Scholar
  132. 132.
    132. Bouchard A, Sanz N, Botvinick EH, et al. Noninvasive assessment of cardiomyopathy in normotensive diabetic patients between 20 and 50 years old. Am J Med. Aug 1989;87(2):160–166.PubMedGoogle Scholar
  133. 133.
    133. Mustonen JN, Uusitupa MI, Tahvanainen K, et al. Impaired left ventricular systolic function during exercise in middle-aged insulin-dependent and noninsulin-dependent diabetic subjects without clinically evident cardiovascular disease. Am J Cardiol. Dec 1 1988;62(17):1273–1279.PubMedGoogle Scholar
  134. 134.
    134. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled T2DM: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. Jan 2001;24(1):5–10.PubMedGoogle Scholar
  135. 135.
    135. Poirier P, Garneau C, Bogaty P, et al. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled T2DM mellitus. Am J Cardiol. Feb 15 2000;85(4):473–477.PubMedGoogle Scholar
  136. 136.
    136. Regan TJ, Lyons MM, Ahmed SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. Oct 1977;60(4):884–899.PubMedGoogle Scholar
  137. 137.
    137. Shimizu M, Sugihara N, Kita Y, Shimizu K, Shibayama S, Takeda R. Increase in left ventricular chamber stiffness in patients with non-insulin dependent diabetes mellitus. Jpn Circ J. Jul 1991;55(7):657–664.PubMedGoogle Scholar
  138. 138.
    138. Robillon JF, Sadoul JL, Jullien D, Morand P, Freychet P. Abnormalities suggestive of cardiomyopathy in patients with T2DM of relatively short duration. Diabetes Metab.Sep–Oct 1994;20(5):473–480.Google Scholar
  139. 139.
    139. Uusitupa M, Mustonen J, Laakso M, et al. Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia. Nov 1988;31(11):783–791.PubMedGoogle Scholar
  140. 140.
    140. Regensteiner J, Groves, BM, Bauer, TA, Reusch JEB, Smith, SC, Wolfel, EE. Recently diagnosed T2DM mellitus adversely affects cardiac function during exercise. Diabetes. 2002;51 (Suppl):A59.Google Scholar
  141. 141.
    141. Oakes ND, Thalen P, Aasum E, et al. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Am J Physiol Endocrinol Metab. May 2006;290(5):E870–E881.PubMedGoogle Scholar
  142. 142.
    142. Mazumder PK, O'Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. Sep 2004;53(9):2366–2374.PubMedGoogle Scholar
  143. 143.
    143. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. May 15 2005;1734(2):112–126.PubMedGoogle Scholar
  144. 144.
    144. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. May 11 2004;109(18):2191–2196.PubMedGoogle Scholar
  145. 145.
    145. Knuuti J, Takala TO, Nagren K, et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia. Feb 2001;44(2):184–187.PubMedGoogle Scholar
  146. 146.
    146. Lowell BB, Shulman GI. Mitochondrial dysfunction and T2DM. Science. Jan 21 2005;307(5708):384–387.PubMedGoogle Scholar
  147. 147.
    147. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA. Jul 8 2003;100(14):8466–8471.PubMedGoogle Scholar
  148. 148.
    148. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis. Curr Atheroscler Rep. Feb 2005;7(1):63–70.PubMedGoogle Scholar
  149. 149.
    149. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol. Feb 20 2002;39(4):718–725.PubMedGoogle Scholar
  150. 150.
    150. Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. Apr 20 2001;418(1–2):105–110.PubMedGoogle Scholar
  151. 151.
    151. Lopaschuk GD. Targets for modulation of fatty acid oxidation in the heart. Curr Opin Investig Drugs. Mar 2004;5(3):290–294.PubMedGoogle Scholar
  152. 152.
    152. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in T2DM and obesity. Diabetes. Apr 2001;50(4):817–823.PubMedGoogle Scholar
  153. 153.
    153. Williamson JR, Kilo C. Capillary basement membranes in diabetes. Diabetes. May 1983;32 Suppl 2:96–100.PubMedGoogle Scholar
  154. 154.
    154. Behnke BJ, Kindig CA, McDonough P, Poole DC, Sexton WL. Dynamics of microvascular oxygen pressure during rest-contraction transition in skeletal muscle of diabetic rats. Am J Physiol Heart Circ Physiol. Sep 2002;283(3):H926–H932.PubMedGoogle Scholar
  155. 155.
    155. Kindig CA, Sexton WL, Fedde MR, Poole DC. Skeletal muscle microcirculatory structure and hemodynamics in diabetes. Respir Physiol. Feb 1998;111(2):163–175.PubMedGoogle Scholar
  156. 156.
    156. Padilla DJ, McDonough P, Behnke BJ, et al. Effects of Type II diabetes on capillary hemodynamics in skeletal muscle. Am J Physiol Heart Circ Physiol. Nov 2006;291(5):H2439–H2444.PubMedGoogle Scholar
  157. 157.
    157. MacRury SM, Small M, MacCuish AC, Lowe GD. Association of hypertension with blood viscosity in diabetes. Diabetes Med. Dec 1988;5(9):830–834.Google Scholar
  158. 158.
    158. McMillan DE. Exercise and diabetic microangiopathy. Diabetes. Jan 1979;28 Suppl 1:103–106.PubMedGoogle Scholar
  159. 159.
    159. Estacio RO, Regensteiner JG, Wolfel EE, Jeffers B, Dickenson M, Schrier RW. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care. Feb 1998;21(2):291–295.PubMedGoogle Scholar
  160. 160.
    160. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in T2DM. Diabetes. Oct 2002;51(10):2944–2950.PubMedGoogle Scholar
  161. 161.
    161. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and T2DM. Diabetes. Jan 2005;54(1):8–14.PubMedGoogle Scholar
  162. 162.
    162. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol. Jul 1997;83(1):166–171.PubMedGoogle Scholar
  163. 163.
    163. Rabol R, Boushel R, Dela F. Mitochondrial oxidative function and T2DM. Appl Physiol Nutr Metab. Dec 2006;31(6):675–683.PubMedGoogle Scholar
  164. 164.
    164. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F. Patients with T2DM have normal mitochondrial function in skeletal muscle. Diabetologia. Apr 2007;50(4):790–796.PubMedGoogle Scholar
  165. 165.
    165. Marin P, Andersson B, Krotkiewski M, Bjorntorp P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care. May 1994;17(5):382–386.PubMedGoogle Scholar
  166. 166.
    166. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA. Effects of exercise on glucose tolerance and insulin resistance. Brief review and some preliminary results. Acta Med Scand Suppl. 1986;711:55–65.Google Scholar
  167. 167.
    167. Verity LS, Ismail AH. Effects of exercise on cardiovascular disease risk in women with NIDDM. Diabetes Res Clin Pract. Jan 3 1989;6(1):27–35.PubMedGoogle Scholar
  168. 168.
    168. Berntorp K, Lindgarde F, Malmquist J. High and low insulin responders: relations to oral glucose tolerance, insulin secretion and physical fitness. Acta Med Scand. 1984;216(1):111–117.Google Scholar
  169. 169.
    169. King DS, Dalsky GP, Clutter WE, et al. Effects of exercise and lack of exercise on insulin sensitivity and responsiveness. J Appl Physiol. May 1988;64(5):1942–1946.PubMedGoogle Scholar
  170. 170.
    170. Heath GW, Gavin JR, III, Hinderliter JM, Hagberg JM, Bloomfield SA, Holloszy JO. Effects of exercise and lack of exercise on glucose tolerance and insulin sensitivity. J Appl Physiol. Aug 1983;55(2):512–517.PubMedGoogle Scholar
  171. 171.
    171. LeBlanc J, Nadeau A, Boulay M, Rousseau-Migneron S. Effects of physical training and adiposity on glucose metabolism and 125I-insulin binding. J Appl Physiol. Feb 1979;46(2):235–239.PubMedGoogle Scholar
  172. 172.
    172. Burstein R, Polychronakos C, Toews CJ, MacDougall JD, Guyda HJ, Posner BI. Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changes. Diabetes. Aug 1985;34(8):756–760.PubMedGoogle Scholar
  173. 173.
    173. Galbo H, Hedeskov CJ, Capito K, Vinten J. The effect of physical training on insulin secretion of rat pancreatic islets. Acta Physiol Scand. Jan 1981;111(1):75–79.PubMedGoogle Scholar
  174. 174.
    174. Douen AG, Ramlal T, Cartee GD, Klip A. Exercise modulates the insulin-induced translocation of glucose transporters in rat skeletal muscle. FEBS Lett. Feb 26 1990;261(2):256–260.PubMedGoogle Scholar
  175. 175.
    175. Brenner DA, Apstein CS, Saupe KW. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation. Jul 10 2001;104(2):221–226.PubMedGoogle Scholar
  176. 176.
    176. Sakamoto S, Minami K, Niwa Y, et al. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM. Diabetes. Jan 1998;47(1):82–86.PubMedGoogle Scholar
  177. 177.
    177. Vanoverschelde JJ, Essamri B, Vanbutsele R, et al. Contribution of left ventricular diastolic function to exercise capacity in normal subjects. J Appl Physiol. May 1993;74(5):2225–2233.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Irene Schauer
    • 1
  • Tim Bauer
  • Peter Watson
    • 1
  • Judith Regensteiner
    • 2
  • Jane E.B. Reusch
    • 1
  1. 1.Division of Endocrinology, Metabolism and DiabetesDepartment of Medicine,University of Colorado DenverAuroraUSA
  2. 2.Divisions of General Internal Medicine and CardiologyDepartment of Medicine, University of Colorado DenverAuroraUSA

Personalised recommendations